Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective

PURPOSE: According to the results of FLOT4 trial, perioperative FLOT chemotherapy improved overall survival (OS) in locally advanced, resectable esophagogastric adenocarcinoma (EGA) compared to perioperative ECF/ECX. We report real-life data 10 years after introduction of perioperative FLOT at our i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sisic, Leila, Crnovrsanin, Nerma, Nienhueser, Henrik, Jung, Jin-On, Schiefer, Sabine, Haag, Georg Martin, Bruckner, Thomas, Schneider, Martin, Müller-Stich, Beat P., Büchler, Markus W., Schmidt, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918580/
https://www.ncbi.nlm.nih.gov/pubmed/36763220
http://dx.doi.org/10.1007/s00423-023-02822-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918580/
https://www.ncbi.nlm.nih.gov/pubmed/36763220
http://dx.doi.org/10.1007/s00423-023-02822-7

Ejemplares similares